1 |
0.02% fm, sh, 0.05% csa |
- |
- |
- |
- |
053 [1] 53 💬 |
2 |
11c-csar |
- |
- |
- |
- |
093 [2] 93, 94 💬 |
3 |
3 mpdn pulse + pdn + csa |
- |
- |
- |
- |
050 [1] 50 💬 |
4 |
Cohort 1: hatg, csa, epag day 14 to month 6 |
Antilymphocyte immunoglobulin (horse) |
[1] D08808 D08808 💬 |
- |
- |
060 [1] 60 💬 |
5 |
Cohort 2: hatg, csa, epag day 14 to month 3 |
Antilymphocyte immunoglobulin (horse) |
[1] D08808 D08808 💬 |
- |
- |
060 [1] 60 💬 |
6 |
Cohort 3: hatg, csa (dose reduced), epag day 1 to month 6 |
Antilymphocyte immunoglobulin (horse) |
[1] D08808 D08808 💬 |
- |
- |
060 [1] 60 💬 |
7 |
Csa |
- |
- |
- |
- |
019 [8] 19, 49, 50, 53, 60, 63, 222, 228 💬 |
8 |
Cyclosporine a (csa) |
Cyclosporine |
[1] D00184 D00184 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
019 [2] 19, 60 💬 |
9 |
Ist (atg + csa) |
- |
- |
- |
- |
060 [1] 60 💬 |
10 |
L-csa |
- |
- |
- |
- |
228 [1] 228 💬 |